Long-term cross-sex hormone treatment is safe in transsexual subjects

The European Journal of Endocrinology recently published a paper (Asscheman et al.) presenting mortality data from more than a thousand transsexuals followed for a median time of 18 years and who had undergone previous or were currently on long term cross-sex hormonal treatment. Transsexualism is a...

Full description

Saved in:
Bibliographic Details
Published in:Asian journal of andrology 2012-11, Vol.14 (6), p.813-814
Main Authors: Meriggiola, Maria Cristina, Berra, Marta
Format: Article
Language:English
Subjects:
Research Highlight
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c409t-68cd9fe4be35007734ca6a50365f877d241f566d6772d4d42417ea1e69bf99153
cites cdi_FETCH-LOGICAL-c409t-68cd9fe4be35007734ca6a50365f877d241f566d6772d4d42417ea1e69bf99153
container_end_page 814
container_issue 6
container_start_page 813
container_title Asian journal of andrology
container_volume 14
creator Meriggiola, Maria Cristina
Berra, Marta
description The European Journal of Endocrinology recently published a paper (Asscheman et al.) presenting mortality data from more than a thousand transsexuals followed for a median time of 18 years and who had undergone previous or were currently on long term cross-sex hormonal treatment. Transsexualism is a rare condition and in scientific literature there are few reports on the long-term safety of different treatment protocols and on the physical and psychological outcomes of medical treatments. The safety of long-term high doses oestrogen or testosterone in subjects of the opposite sex has been debated and data on long term effects are scant at best. The Asscherman paper therefore represents a very important and reassuring reference for professionals working in this field suggesting that mortality is increased among transsexuals although due to causes unrelated to cross sex replacement therapy. These results will benefit the care and treatment of these subjects.
doi_str_mv 10.1038/aja.2012.89
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3720111</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2808170321</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-68cd9fe4be35007734ca6a50365f877d241f566d6772d4d42417ea1e69bf99153</originalsourceid><addsrcrecordid>eNpdkc1LxDAQxYMorq6evEvBiyBd89WmuQiyrB-w4EXBW0jb6W6XNlmTVvS_N3XXRT3NTPLj8WYeQmcETwhm2bVe6QnFhE4yuYeOiOBJLGhK90OPcRanGX0doWPvVxhTRqQ8RCNKJR36IzSbW7OIO3BtVDjrfezhI1pa11oDUedAdy2YLqp95HUFUW3CozY-UL1uIt_nKyg6f4IOKt14ON3WMXq5mz1PH-L50_3j9HYeFxzLLlgpSlkBz4ElGAvBeKFTnWCWJlUmREk5qZI0LVMhaMlLHmYBmkAq80pKkrAxutnorvu8hbII1pxu1NrVrXafyupa_f0x9VIt7LtiIlyIkCBwuRVw9q0H36m29gU0jTZge68I4UzihHAe0It_6Mr2zoT1AsUyRnEmBkdXG-r7eg6qnRmC1RCPCvGoIR6VyUCf__a_Y3_yYF8Geor8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1138320875</pqid></control><display><type>article</type><title>Long-term cross-sex hormone treatment is safe in transsexual subjects</title><source>PubMed Central</source><creator>Meriggiola, Maria Cristina ; Berra, Marta</creator><creatorcontrib>Meriggiola, Maria Cristina ; Berra, Marta</creatorcontrib><description>The European Journal of Endocrinology recently published a paper (Asscheman et al.) presenting mortality data from more than a thousand transsexuals followed for a median time of 18 years and who had undergone previous or were currently on long term cross-sex hormonal treatment. Transsexualism is a rare condition and in scientific literature there are few reports on the long-term safety of different treatment protocols and on the physical and psychological outcomes of medical treatments. The safety of long-term high doses oestrogen or testosterone in subjects of the opposite sex has been debated and data on long term effects are scant at best. The Asscherman paper therefore represents a very important and reassuring reference for professionals working in this field suggesting that mortality is increased among transsexuals although due to causes unrelated to cross sex replacement therapy. These results will benefit the care and treatment of these subjects.</description><identifier>ISSN: 1008-682X</identifier><identifier>EISSN: 1745-7262</identifier><identifier>DOI: 10.1038/aja.2012.89</identifier><identifier>PMID: 22922319</identifier><language>eng</language><publisher>China: Medknow Publications &amp; Media Pvt. Ltd</publisher><subject>Research Highlight</subject><ispartof>Asian journal of andrology, 2012-11, Vol.14 (6), p.813-814</ispartof><rights>Copyright Nature Publishing Group Nov 2012</rights><rights>Copyright © 2012 SIMM &amp; SJTU 2012 SIMM &amp; SJTU</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-68cd9fe4be35007734ca6a50365f877d241f566d6772d4d42417ea1e69bf99153</citedby><cites>FETCH-LOGICAL-c409t-68cd9fe4be35007734ca6a50365f877d241f566d6772d4d42417ea1e69bf99153</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720111/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720111/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22922319$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meriggiola, Maria Cristina</creatorcontrib><creatorcontrib>Berra, Marta</creatorcontrib><title>Long-term cross-sex hormone treatment is safe in transsexual subjects</title><title>Asian journal of andrology</title><addtitle>Asian J Androl</addtitle><description>The European Journal of Endocrinology recently published a paper (Asscheman et al.) presenting mortality data from more than a thousand transsexuals followed for a median time of 18 years and who had undergone previous or were currently on long term cross-sex hormonal treatment. Transsexualism is a rare condition and in scientific literature there are few reports on the long-term safety of different treatment protocols and on the physical and psychological outcomes of medical treatments. The safety of long-term high doses oestrogen or testosterone in subjects of the opposite sex has been debated and data on long term effects are scant at best. The Asscherman paper therefore represents a very important and reassuring reference for professionals working in this field suggesting that mortality is increased among transsexuals although due to causes unrelated to cross sex replacement therapy. These results will benefit the care and treatment of these subjects.</description><subject>Research Highlight</subject><issn>1008-682X</issn><issn>1745-7262</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpdkc1LxDAQxYMorq6evEvBiyBd89WmuQiyrB-w4EXBW0jb6W6XNlmTVvS_N3XXRT3NTPLj8WYeQmcETwhm2bVe6QnFhE4yuYeOiOBJLGhK90OPcRanGX0doWPvVxhTRqQ8RCNKJR36IzSbW7OIO3BtVDjrfezhI1pa11oDUedAdy2YLqp95HUFUW3CozY-UL1uIt_nKyg6f4IOKt14ON3WMXq5mz1PH-L50_3j9HYeFxzLLlgpSlkBz4ElGAvBeKFTnWCWJlUmREk5qZI0LVMhaMlLHmYBmkAq80pKkrAxutnorvu8hbII1pxu1NrVrXafyupa_f0x9VIt7LtiIlyIkCBwuRVw9q0H36m29gU0jTZge68I4UzihHAe0It_6Mr2zoT1AsUyRnEmBkdXG-r7eg6qnRmC1RCPCvGoIR6VyUCf__a_Y3_yYF8Geor8</recordid><startdate>20121101</startdate><enddate>20121101</enddate><creator>Meriggiola, Maria Cristina</creator><creator>Berra, Marta</creator><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Nature Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20121101</creationdate><title>Long-term cross-sex hormone treatment is safe in transsexual subjects</title><author>Meriggiola, Maria Cristina ; Berra, Marta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-68cd9fe4be35007734ca6a50365f877d241f566d6772d4d42417ea1e69bf99153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Research Highlight</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meriggiola, Maria Cristina</creatorcontrib><creatorcontrib>Berra, Marta</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Asian journal of andrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meriggiola, Maria Cristina</au><au>Berra, Marta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term cross-sex hormone treatment is safe in transsexual subjects</atitle><jtitle>Asian journal of andrology</jtitle><addtitle>Asian J Androl</addtitle><date>2012-11-01</date><risdate>2012</risdate><volume>14</volume><issue>6</issue><spage>813</spage><epage>814</epage><pages>813-814</pages><issn>1008-682X</issn><eissn>1745-7262</eissn><abstract>The European Journal of Endocrinology recently published a paper (Asscheman et al.) presenting mortality data from more than a thousand transsexuals followed for a median time of 18 years and who had undergone previous or were currently on long term cross-sex hormonal treatment. Transsexualism is a rare condition and in scientific literature there are few reports on the long-term safety of different treatment protocols and on the physical and psychological outcomes of medical treatments. The safety of long-term high doses oestrogen or testosterone in subjects of the opposite sex has been debated and data on long term effects are scant at best. The Asscherman paper therefore represents a very important and reassuring reference for professionals working in this field suggesting that mortality is increased among transsexuals although due to causes unrelated to cross sex replacement therapy. These results will benefit the care and treatment of these subjects.</abstract><cop>China</cop><pub>Medknow Publications &amp; Media Pvt. Ltd</pub><pmid>22922319</pmid><doi>10.1038/aja.2012.89</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1008-682X
ispartof Asian journal of andrology, 2012-11, Vol.14 (6), p.813-814
issn 1008-682X
1745-7262
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3720111
source PubMed Central
subjects Research Highlight
title Long-term cross-sex hormone treatment is safe in transsexual subjects
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A27%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20cross-sex%20hormone%20treatment%20is%20safe%20in%20transsexual%20subjects&rft.jtitle=Asian%20journal%20of%20andrology&rft.au=Meriggiola,%20Maria%20Cristina&rft.date=2012-11-01&rft.volume=14&rft.issue=6&rft.spage=813&rft.epage=814&rft.pages=813-814&rft.issn=1008-682X&rft.eissn=1745-7262&rft_id=info:doi/10.1038/aja.2012.89&rft_dat=%3Cproquest_pubme%3E2808170321%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c409t-68cd9fe4be35007734ca6a50365f877d241f566d6772d4d42417ea1e69bf99153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1138320875&rft_id=info:pmid/22922319&rfr_iscdi=true